{"created":"2023-06-19T07:11:01.617742+00:00","id":1564,"links":{},"metadata":{"_buckets":{"deposit":"9192e54a-c94c-4a78-963b-594046716f14"},"_deposit":{"created_by":14,"id":"1564","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"1564"},"status":"published"},"_oai":{"id":"oai:kurume.repo.nii.ac.jp:00001564","sets":["6:264"]},"author_link":["1792"],"item_2_alternative_title_1":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"一般住民において血清Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)値はインスリン抵抗性、中性脂肪、Lipoprotein(a)の血中濃度と関連しているが、低密度リポ蛋白コレステロール値とは関連していない","subitem_alternative_title_language":"ja"}]},"item_2_date_granted_9":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2020-11-01"}]},"item_2_degree_grantor_7":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"久留米大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"37104","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_2_degree_name_6":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_2_description_8":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_description":"2020年度","subitem_description_type":"Other"}]},"item_2_dissertation_number_10":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"乙第2978号"}]},"item_2_relation_11":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"32624555","subitem_relation_type_select":"PMID"}}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.5551/jat.56390","subitem_relation_type_select":"DOI"}}]},"item_2_relation_14":{"attribute_name":"情報源","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"Journal of atherosclerosis and thrombosis 28(4):329-337, 2021"}],"subitem_relation_type":"isIdenticalTo"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"濱村, 仁士","creatorNameLang":"ja"},{"creatorName":"ハマムラ, ヒトシ","creatorNameLang":"ja-Kana"},{"creatorName":"Hamamura, Hitoshi","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1792","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-08-04"}],"displaytype":"detail","filename":"37104B2978.pdf","filesize":[{"value":"293.8 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://kurume.repo.nii.ac.jp/record/1564/files/37104B2978.pdf"},"version_id":"1b8dd724-d144-47d5-b12a-6a3d33024ce2"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-08-04"}],"displaytype":"detail","filename":"37104B2978youshi.pdf","filesize":[{"value":"85.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"要旨","objectType":"abstract","url":"https://kurume.repo.nii.ac.jp/record/1564/files/37104B2978youshi.pdf"},"version_id":"5642cae3-ce7a-4cab-914e-20e8b1e28c6f"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Epidemiology","subitem_subject_scheme":"Other"},{"subitem_subject":"Insulin resistance","subitem_subject_scheme":"Other"},{"subitem_subject":"Lipoprotein(a)","subitem_subject_scheme":"Other"},{"subitem_subject":"Proprotein convertase subtilisin/kexin type 9 (PCSK9)","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels, but not Low-density Lipoprotein Cholesterol Levels in a General Population","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels, but not Low-density Lipoprotein Cholesterol Levels in a General Population","subitem_title_language":"en"}]},"item_type_id":"2","owner":"14","path":["264"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-08-04"},"publish_date":"2021-08-04","publish_status":"0","recid":"1564","relation_version_is_last":true,"title":["Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels, but not Low-density Lipoprotein Cholesterol Levels in a General Population"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-10-05T02:36:08.963823+00:00"}